PCSK9 and familial hyperaldosteronism: Gain-of-function abnormalities in the PCSK9 gene result in FH and a greater risk of ACD, while loss-of-function abnormalities are a cause of lower LDL concentrations in blood and reduced risk of coronary heart disease.